CIK 0001778922
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SpyGlass Pharma, Inc.
Sign in to watch- Ticker
- SGP
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 833044245
- Phone
- +1 949-284-6904
- Business address
- 15326 ALTON PARKWAY, IRVINE, CA, 92618
- Former names
- SpyGlassPharma, Inc., SpyGlass Ophthalmics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-05 | Scheiner Zachary Director | Grant or award · Stock Option (right to buy) | +27,400 | 27,400 | ||
| 2026-02-05 | Pardo Geoffrey B Director | Grant or award · Stock Option (right to buy) | +27,400 | 27,400 | ||
| 2026-02-05 | O'Farrell Elizabeth G. Director | Grant or award · Stock Option (right to buy) | +13,700 | 13,700 | ||
| 2026-02-05 | Dable Habib J Director | Grant or award · Stock Option (right to buy) | +27,400 | 27,400 | ||
| 2026-02-05 | Dybbs Michael Director | Grant or award · Stock Option (right to buy) | +27,400 | 27,400 | ||
| 2026-02-05 | Nielsen Kirk G. Director | Grant or award · Stock Option (right to buy) | +27,400 | 27,400 | ||
| 2026-02-05 | Viret Jean-Frederic Chief Financial Officer | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2026-02-05 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (right to buy) | +27,400 | 27,400 | ||
| 2026-02-05 | Behbahani Ali Director | Grant or award · Stock Option (right to buy) | +27,400 | 27,400 |
Page 9 of 9 · 169 trades